Using Qiagen’s competence in extraction and amplification reagents for pre-processing and Hitachi’s know-how in equiment technology, a fully automated gene analyzer and next-generation sequencer based on the PCR method will be developed. Major applications will be in disease analysis and genetic testing, with a vision to do complex genetic testing for cancer diagnosis.

Hitachi High-Tech news release, June 18, 2015